文献速递乳腺外科围术期管理与 ERAS

乳腺癌手术及乳房重建中吲哚菁绿荧光成像的双系统综述与成本分析

Fluorescence imaging with indocyanine green during breast cancer surgery and postmastectomy breast reconstruction: A double systematic review and cost analysis.
PubMed 文献 · Surgery · 2026-01-21

该双系统综述与成本分析检索PubMed、EMBASE和Scopus,纳入前哨淋巴结检测5项研究(ICG组1484例,对照组1697例)和乳房重建5项研究(ICG血管造影组1446例,对照组1339例)。结果显示,前哨淋巴结检测中ICG每例节省175至1241美元(均值474美元),乳房重建中每例成本从平均亏损3美元至节省1160美元(均值节省553美元)。结论认为ICG荧光成像可能通过消除锝-99m需求和减少灌注相关并发症显著降低费用。

要点

  • ICG荧光成像在前哨淋巴结检测中每例平均节省474美元。
  • ICG血管造影在乳房重建中每例平均节省553美元。
  • 成本降低源于消除锝-99m需求和减少灌注相关并发症。

核心结论

  • 乳腺癌手术及乳房重建中使用ICG荧光成像似乎可显著降低费用。

研究设计与样本

  • 双系统综述与成本分析,由多学科团队检索PubMed、EMBASE和Scopus。
  • 前哨淋巴结检测纳入5项研究,ICG组1484例,对照组1697例。
  • 乳房重建纳入5项研究,ICG血管造影组1446例,对照组1339例。
  • 使用改良Downs and Black工具评估研究质量。

主要发现

  • 前哨淋巴结检测中ICG每例节省175至1241美元(均值474美元)。
  • 乳房重建中ICG血管造影每例成本从平均亏损3美元至节省1160美元(均值节省553美元)。

临床怎么用

  • 在乳腺癌前哨淋巴结检测中可考虑ICG荧光成像以替代锝-99m±蓝染料并降低费用。
  • 在乳房切除后重建中可使用ICG血管造影评估灌注以减少并发症和再手术及相关费用。

局限性

  • 仍需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Level I evidence argues that indocyanine green fluorescence imaging, used alone, is either noninferior or superior to current gold standards of technetium Tc 99m ± blue dye for detecting sentinel lymph nodes during breast cancer surgery. Extensive literature also shows that perfusion assessments using indocyanine green fluorescence angiography reduce the rates of perfusion-related complications, including flap necrosis and necessary reoperations during breast reconstruction after mastectomy. Our objective was to examine the relative costs of using indocyanine green fluorescence imaging for breast cancer resection and breast reconstruction. METHODS: A multidisciplinary team performed an extensive review of published literature spanning PubMed, EMBASE, and Scopus. Cost analysis was conducted for studies meeting stringent eligibility criteria that included the need for detailed data on both variable and fixed costs, both of the procedures and potential complications. Study quality was assessed using the modified Downs and Black Quality Assessment tool. RESULTS: Overall, 2,095 and 993 abstracts were screened for sentinel lymph node detection and postmastectomy breast reconstruction, respectively, leading to 5 studies with 1,484 indocyanine green fluorescence imaging patients and 1,697 control patients for sentinel lymph node detection and 5 studies with 1,446 indocyanine green fluorescence angiography patients and 1,339 control patients for breast reconstruction. For sentinel lymph node detection, per-patient savings using indocyanine green fluorescence imaging ranged from US $175 to US $1,241 (mean = US $474). For breast reconstruction, per-patient costs of indocyanine green fluorescence angiography ranged from a mean US $3 loss to US $1,160 savings (mean = US $553 saved). CONCLUSION: Although further studies remain necessary, using indocyanine green fluorescence imaging during breast cancer surgery and breast reconstruction appears to appreciably lower costs, both by eliminating the need for technetium Tc 99m and by reducing perfusion-related complications.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Goldhawk-White P, White KP, Doeksen A, et al. Fluorescence imaging with indocyanine green during breast cancer surgery and postmastectomy breast reconstruction: A double systematic review and cost analysis. Surgery. 2026. PMID: 41570662. doi:10.1016/j.surg.2025.110052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。